Optimizing Process Development for Biologics

Watch Daniel Giroux, VP of Biologics Development at Abzena, as he discusses approaches for optimizing process development for the production of proteins.

The development and production of biologics is often a complex process. Biologics in themselves are complex molecules. Their manufacture requires that processes are developed and validated so that product specifications can be met to create a safe and effective biologic drug. Sponsor companies often look to contract development and manufacturing organizations (CDMOs), like Abzena, to help with the process development and optimization of these products.

To learn more about biologics process development, specifically for protein production, BioPharm International® spoke with Daniel Giroux, VP of Biologics Development at Abzena to gain his perspective on cell culture, upstream processing, cell harvesting, and validation requirements.

Watch Daniel’s presentation here